Back to speakers

Eugene SCHIFF

Director, Schiff Center for Liver Diseases

USA

City: Miami, FL

Institution: University of Miami

Contact: Eschiff@med.miami.edu


Biography of Eugene SCHIFF

Eugene R. Schiff, MD, MACP, FRCP, MACG, AGAF Leonard Miller Professor of Medicine, Dr. Nasser Ibrahim Al-Rashid Chair in the Division of Hepatology/UM Center for Liver Diseases, Director for the Schiff Center for Liver Diseases at the University of Miami Miller School of Medicine in Miami, Florida.

 

Dr. Schiff earned his BA at the University of Michigan in Ann Arbor, and his MD at Columbia University College of Physicians and Surgeons in New York City. After graduating, he completed his internship at Cincinnati General Hospital in Cincinnati, Ohio, and his residencies in internal medicine at Cincinnati General Hospital and Parkland Memorial Hospital in Dallas, Texas. His fellowship in Gastroenterology was conducted at the University of Texas Southwestern Medical School in Dallas.

 

Dr. Schiff is the co-editor of the Eleventh Edition of Schiff’s Diseases of the Liver and has authored and co-authored more than 400 articles, books, book chapters concerning liver diseases and related topics. His articles have been published in the Journal of the American Medical Association, Journal of Clinical Investigation, Hepatology, Journal of Hepatology, Liver Transplantation, New England Journal of Medicine, Annals of Internal Medicine and Gastroenterology. He is the past President of the American Association for the Study of Liver Diseases, past Chairman of the Biliary Section of the American Gastroenterological Association. Dr. Schiff is a Master of the American College of Gastroenterology, a Master of the American College of Physicians, a Fellow of the Royal College of Physicians and a Fellow of the American Gastroenterology Association. He was the Governor of the American College of Physicians for the State of Florida for four years. He was a member of the Gastroenterology Subspecialty Board of the American Board of Internal Medicine and former Chair of the FDA Advisory Committee on gastrointestinal drugs. Dr. Schiff is the recipient of numerous honors and awards, including the Florida Laureate Award presented by the American College of Physicians, the Distinguished Service award of the American Association for the Study of Liver Diseases, the Society of the Professors of Medicine Lifetime Achievement Award and was honored as the first recipient of the Emmet B Keeffe Mentorship Award.

PHC's participations

10th PHC – 2017

Monday, January 30th 2017

Impact of therapy in a patient F1

9th PHC – 2016

Monday, January 11th 2016

How to optimize the strategy against HCV? (chairman)

8th PHC – 2015

Monday, January 12th 2015

Controversy: Cure of HCV-related liver disease? (chairman)

Tuesday, January 13th 2015

Viral hepatitis: the past and the future -

7th PHC – 2014

Monday, January 13th 2014

Controversy: F1/F2 patients: treat or wait? (chairman)

6th PHC – 2013

Monday, January 14th 2013

Interactive luncheons - Room 4 (chairman)

Tuesday, January 15th 2013

Optimal therapy of HBeAg-positive chronic hepatitis B (chairman)

5th PHC – 2012

Monday, January 30th 2012

Triple therapy today. Phase III results in G1 relapsers and non responders (chairman)

Tuesday, January 31st 2012

Interactive Luncheons - Room 6 (chairman)

4th PHC – 2011

Monday, January 17th 2011

Clinical case: management of a non responder -

3rd PHC – 2009

Monday, January 19th 2009

Luncheons - Room 3 (chairman)

Clinical case

2nd PHC – 2007

Tuesday, January 23rd 2007

HBeAg negative chronic hepatitis B (chairman)

1st PHC – 2004

Friday, September 10th 2004

Case Study in the Management of Patients with Hepatocellular Carcinoma (chairman) -

10th PHC – 2017

Monday, January 30th 2017

Impact of therapy in a patient F1 -

11th PHC – 2018

Monday, January 15th 2018

Management of a patient with HCV related vasculitis